Zacks Research Issues Optimistic Forecast for CRSP Earnings
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Investment analysts at Zacks Research boosted their Q2 2025 earnings per share estimates for shares of CRISPR Therapeutics in a note issued to investors on Tuesday, May 27th. Zacks Research analyst R. Department now forecasts that the company will earn ($1.58) per share for the quarter, up […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Investment analysts at Zacks Research boosted their Q2 2025 earnings per share estimates for shares of CRISPR Therapeutics in a note issued to investors on Tuesday, May 27th. Zacks Research analyst R. Department now forecasts that the company will earn ($1.58) per share for the quarter, up […]
